ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1028

Lupus Auto-antibodies Act as Positive Allosteric Modulators at GluN2A-containing NMDA Receptors to Induce Excitotoxicity and Spatial Memory Deficits

Kelvin Chan1, Jacquelyn Nestor 2, Tomas Huerta 2, Czeslawa Kowal 2, Patricio Huerta 2, Bruce Volpe 2, Betty Diamond 3 and Lonnie Wollmuth 1, 1Stony Brook University School of Medicine, Stony Brook, NY, 2Feinstein Institutes for Medical Research, Manhasset, NY, 3Feinstein Institutes for Medical Research, Manhasset

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: anti-dsDNA and neuropsychiatric disorders, autoantibodies, Nervous system lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: SLE – Etiology & Pathogenesis Poster I

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with Systemic lupus erythematosus (SLE) experience various peripheral and central nervous system manifestations including spatial memory impairment. A subset of auto-antibodies (DNRAbs) cross-react with the GluN2A and GluN2B subunits of the NMDA receptor (NMDAR). The underlying subunit specificity for DNRAbs to mediate SLE neuropathological effects are currently unknown. Here, we characterize the specific subunit effects of DNRAbs on NMDA receptors.

Methods: We employ whole-cell and single-channel patch clamp electrophysiology to study the mechanism of potentiating NMDAR currents by DNRAbs. We employ primary neuronal cell cultures, pharmacology, and ICC to test for subunit-specific NMDAR antagonists to block DNRAb-mediated cell death. We employ transgenic animals to selectively knock out NMDAR subunits for immunohistochemistry, microglia assessment, in vivo place field recordings, and spatial memory behavior testing.

Results: We find that these DNRAbs act as positive allosteric modulators on NMDARs with GluN2A-containing NMDARs, even those containing a single GluN2A subunit, exhibiting a much greater sensitivity to DNRAbs than those with exclusively GluN2B. Accordingly, GluN2A-specific antagonists provide greater protection from DNRAb-mediated neuronal cell death than GluN2B antagonists. Using transgenic mice to perturb expression of either GluN2A or GluN2B in vivo, we find that DNRAb-mediated disruption of spatial memory characterized by early neuronal cell death and subsequent microglia-dependent pathologies requires GluN2A-containing NMDARs. Finally, spatial memory defects resulting from aberrant hippocampal place fields affected by DNRAbs require GluN2A-containing NMDARs as well.

Conclusion: Our results indicate that GluN2A is the primary subunit that drives DNRAb-mediated NMDAR potentiation, and SLE cognitive/spatial memory defects. Thus, GluN2A-specific antagonists or negative allosteric modulators are strong candidates to treat SLE patients with nervous system dysfunction.


Disclosure: K. Chan, None; J. Nestor, None; T. Huerta, None; C. Kowal, None; P. Huerta, None; B. Volpe, None; B. Diamond, GSK, 5, Jansen, 5, Lilly, 5; L. Wollmuth, None.

To cite this abstract in AMA style:

Chan K, Nestor J, Huerta T, Kowal C, Huerta P, Volpe B, Diamond B, Wollmuth L. Lupus Auto-antibodies Act as Positive Allosteric Modulators at GluN2A-containing NMDA Receptors to Induce Excitotoxicity and Spatial Memory Deficits [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/lupus-auto-antibodies-act-as-positive-allosteric-modulators-at-glun2a-containing-nmda-receptors-to-induce-excitotoxicity-and-spatial-memory-deficits/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lupus-auto-antibodies-act-as-positive-allosteric-modulators-at-glun2a-containing-nmda-receptors-to-induce-excitotoxicity-and-spatial-memory-deficits/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology